Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion
dc.contributor.author | Zang, Ruochen | |
dc.contributor.author | Case, James Brett | |
dc.contributor.author | Yutuc, Eylan | |
dc.contributor.author | Ma, Xiucui | |
dc.contributor.author | Shen, Sheng | |
dc.contributor.author | Gomez Castro, Maria Florencia | |
dc.contributor.author | Liu, Zhuoming | |
dc.contributor.author | Zeng, Qiru | |
dc.contributor.author | Zhao, Haiyan | |
dc.contributor.author | Son, Juhee | |
dc.contributor.author | Rothlauf, Paul W. | |
dc.contributor.author | Kreutzberger, Alex J. B. | |
dc.contributor.author | Hou, Gaopeng | |
dc.contributor.author | Zhang, Hu | |
dc.contributor.author | Bose, Sayantan | |
dc.contributor.author | Wang, Xin | |
dc.contributor.author | Vahey, Michael D. | |
dc.contributor.author | Mani, Kartik | |
dc.contributor.author | Griffiths, William J. | |
dc.contributor.author | Kirchhausen, Tom | |
dc.contributor.author | Fremont, Daved H. | |
dc.contributor.author | Guo, Haitao | |
dc.contributor.author | Diwan, Abhinav | |
dc.contributor.author | Wang, Yuqin | |
dc.contributor.author | Diamond, Michael S. | |
dc.contributor.author | Whelan, Sean P. J. | |
dc.contributor.author | Ding, Siyuan | |
dc.contributor.department | Microbiology and Immunology, School of Medicine | en_US |
dc.date.accessioned | 2021-04-15T20:10:38Z | |
dc.date.available | 2021-04-15T20:10:38Z | |
dc.date.issued | 2020-12 | |
dc.description.abstract | Cholesterol 25-hydroxylase (CH25H) is an interferon (IFN)-stimulated gene that shows broad antiviral activities against a wide range of enveloped viruses. Here, using an IFN-stimulated gene screen against vesicular stomatitis virus (VSV)-SARS-CoV and VSV-SARS-CoV-2 chimeric viruses, we identified CH25H and its enzymatic product 25-hydroxycholesterol (25HC) as potent inhibitors of SARS-CoV-2 replication. Internalized 25HC accumulates in the late endosomes and potentially restricts SARS-CoV-2 spike protein catalyzed membrane fusion via blockade of cholesterol export. Our results highlight one of the possible antiviral mechanisms of 25HC and provide the molecular basis for its therapeutic development. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Zang, R., Case, J. B., Yutuc, E., Ma, X., Shen, S., Castro, M. F. G., ... & Ding, S. (2020). Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion. Proceedings of the National Academy of Sciences, 117(50), 32105-32113. https://doi.org/10.1073/pnas.2012197117 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/25653 | |
dc.language.iso | en | en_US |
dc.publisher | NAS | en_US |
dc.relation.isversionof | 10.1073/pnas.2012197117 | en_US |
dc.relation.journal | Proceedings of the National Academy of Sciences | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | Publisher | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | interferon | en_US |
dc.subject | virus entry | en_US |
dc.subject | COVID-19 | en_US |
dc.title | Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion | en_US |
dc.type | Article | en_US |